A study on the impact of misophonia on youth and families (September 29, 2022)
Is your child between the age of 5 and 20? Has your child received a diagnosis of misophonia, or do they experience severe sensitivity to certain sounds?
If so, you may be eligible to participate in a study looking at misophonia among children, teenagers, and young adults aged 5-20. Eligible participants will complete a 90-minute visit with an interview and online questionnaires. They will then will be sent monthly 5-10 minute surveys to fill out for six months. Participants are asked to complete a 30-to-60-minute online questionnaire again 6 months after the start of the study.
Participants will be compensated up to $110 ($55 parent and $55 child) for participation.
This study is being conducted by Dr. Andrew Guzick at Baylor College of Medicine, Houston, TX. For more information, please contact the study coordinator, Catherine Rast, at (713) 798-1916 or email firstname.lastname@example.org or complete the attached survey – https://bcmpsych.sjc1.qualtrics.com/…/SV_5tKt9Xd4zDryX78
Participate in a Misophonia Study and Earn up to $150 (August 17, 2022)
Researchers at Johns Hopkins are inviting youth with misophonia to participate in a study. The study will help bring awareness to the condition and evaluate the associative learning processes in youth with and without misophonia. Participation consists of one virtual visit and three in-person visits which can last up to about 10 hours. Participants can earn up to $150 for participation in all of the study visits.
To be eligible to participate, youth must:
– be 8-17 years old
– be an English speaker
– meet the proposed criteria for misophonia
– be able to attend three in-person study visits at the COACH Lab at Johns Hopkins University
For more information about eligibility and participation, contact the COACH study coordinator at COACH@jhmi.edu or 443-300-8836. The JH-COACH is part of the Children’s Center at Johns Hopkins Hospital in Baltimore, MD.
This study is approved by a Johns Hopkins Medicine institutional review board.
IRB00208976, PI: Joseph McGuire, PhD